Q3FY18 in line: Consolidated net sales, EBITDA, and adj. PAT grew 16% (adjusted for GST accounting), 37% and 61% (vs. consensus estimates of 15%, 32% and 100%). Volume grew 11.5% aided by weak base and gradual recovery in supply chain.